Literature DB >> 6068144

In vivo growth and distribution of anthrax bacilli in resistant, susceptible, and immunized hosts.

W I Jones, F Klein, J S Walker, B G Mahlandt, J P Dobbs, R E Lincoln.   

Abstract

Differences in in vivo growth rates of Bacillus anthracis in the bodies of infected rats and guinea pigs showed the effect of innate species resistance. The effect of two levels of immunity imposed on these hosts demonstrated that, as the degree of immunity increased, the growth rate of organisms decreased and was accompanied by a decrease in terminal population. It was shown that growth rates in the blood best reflected the population growth in the entire host. Data obtained from the naturally resistant rat that had been immunized with both the Belton-Strange protective antigen and live vaccine demonstrated the role of "toxins" in terminal anthrax. The in vivo morphological changes in anthrax bacilli pointed out errors regarding estimates of true terminal population of organisms when samples for counting were taken postmortem rather than at the time of death.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6068144      PMCID: PMC251930          DOI: 10.1128/jb.94.3.600-608.1967

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

1.  STUDIES ON ANTHRAX INFECTIONS IN IMMUNIZED GUINEA PIGS.

Authors:  M K WARD; V G MCGANN; A L HOGGE; M L HUFF; R G KANODE; E O ROBERTS
Journal:  J Infect Dis       Date:  1965-02       Impact factor: 5.226

2.  Change in virulence of Bacillus anthracis spores as affected by solids and challenge route.

Authors:  M RHIAN; J M RILEY; V L WOLFE; A H SIMMONS
Journal:  J Infect Dis       Date:  1963 Mar-Apr       Impact factor: 5.226

3.  Immunological studies of anthrax. I. An index to determine quantitative immunization.

Authors:  I A DEARMON; F KLEIN; R E LINCOLN; B G MAHLANDT; A L FERNELIUS
Journal:  J Immunol       Date:  1961-09       Impact factor: 5.422

4.  Immunological studies of anthrox. II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine.

Authors:  F KLEIN; I A DEARMON; R E LINCOLN; B G MAHLANDT; A L FERNELIUS
Journal:  J Immunol       Date:  1962-01       Impact factor: 5.422

5.  Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin.

Authors:  B G Mahlandt; F Klein; R E Lincoln; B W Haines; W I Jones; R H Friedman
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

6.  Immunization as a factor affecting the course of septicemic anthrax.

Authors:  F KLEIN; B G MAHLANDT; R E LINCOLN; I A DEARMON; A L FERNELIUS
Journal:  Science       Date:  1961-03-31       Impact factor: 47.728

7.  DUAL NATURE OF RESISTANCE MECHANISMS AS REVEALED BY STUDIES OF ANTHRAX SEPTICEMIA.

Authors:  F KLEIN; B W HAINES; B G MAHLANDT; I A DEARMON; R E LINCOLN
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

8.  The chemical basis of the virulence of Bacillus anthracis. III. The role of the terminal bacteraemia in death of guinea-pigs from anthrax.

Authors:  J KEPPIE; H SMITH; P W HARRIS-SMITH
Journal:  Br J Exp Pathol       Date:  1955-06

9.  QUANTITATIVE ASSAY FOR CRUDE ANTHRAX TOXINS.

Authors:  B W HAINES; F KLEIN; R E LINCOLN
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

  9 in total
  8 in total

1.  Amino acid- and purine ribonucleoside-induced germination of Bacillus anthracis DeltaSterne endospores: gerS mediates responses to aromatic ring structures.

Authors:  John A W Ireland; Philip C Hanna
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  Multigenic control and sex bias in host susceptibility to spore-induced pulmonary anthrax in mice.

Authors:  Jagjit S Yadav; Suman Pradhan; Renuka Kapoor; Hansraj Bangar; Benjamin B Burzynski; Daniel R Prows; Linda Levin
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

Review 4.  Anthrax: A disease of biowarfare and public health importance.

Authors:  Ajay Kumar Goel
Journal:  World J Clin Cases       Date:  2015-01-16       Impact factor: 1.337

5.  Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Authors:  Yves P Gauthier; Jean-Nicolas Tournier; Jean-Charles Paucod; Jean-Philippe Corre; Michèle Mock; Pierre L Goossens; Dominique R Vidal
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

Review 6.  Recent advances in the development of an improved, human anthrax vaccine.

Authors:  B E Ivins; S L Welkos
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

Review 7.  Anthrax lethal toxin and the induction of CD4 T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Daniel M Altmann
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

8.  Global genetic population structure of Bacillus anthracis.

Authors:  Matthew N Van Ert; W Ryan Easterday; Lynn Y Huynh; Richard T Okinaka; Martin E Hugh-Jones; Jacques Ravel; Shaylan R Zanecki; Talima Pearson; Tatum S Simonson; Jana M U'Ren; Sergey M Kachur; Rebecca R Leadem-Dougherty; Shane D Rhoton; Guenevier Zinser; Jason Farlow; Pamala R Coker; Kimothy L Smith; Bingxiang Wang; Leo J Kenefic; Claire M Fraser-Liggett; David M Wagner; Paul Keim
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.